Pages that link to "Q81440554"
Jump to navigation
Jump to search
The following pages link to ERCC1-immunoexpression does not predict platinum-resistance in ovarian cancer (Q81440554):
Displaying 8 items.
- Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study (Q30419554) (← links)
- MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity (Q36105442) (← links)
- High ERCC1 expression is associated with platinum-resistance, but not survival in patients with epithelial ovarian cancer (Q37108536) (← links)
- Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies (Q37328373) (← links)
- High IL-17-positive tumor immune cell infiltration is indicative for chemosensitivity of ovarian carcinoma (Q51035347) (← links)
- High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy. (Q55017240) (← links)
- Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; A Gynecologic Oncology Group Study (Q83877786) (← links)
- Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma (Q84781471) (← links)